54 related articles for article (PubMed ID: 1647061)
1. Virus safety of pasteurized antithrombin III concentrate.
Roggendorf M; Delvos U; Nováková-Banet A
Thromb Haemost; 1991 Feb; 65(2):212. PubMed ID: 1647061
[No Abstract] [Full Text] [Related]
2. Characterization and viral safety validation study of a pasteurized therapeutic concentrate of antithrombin III obtained through affinity chromatography.
Biescas H; Gensana M; Fernández J; Ristol P; Massot M; Watson E; Vericat F
Haematologica; 1998 Apr; 83(4):305-11. PubMed ID: 9592979
[TBL] [Abstract][Full Text] [Related]
3. A pasteurized antithrombin III concentrate for clinical use.
Smith JK; Winkelman L; Evans DR; Haddon ME; Sims G
Vox Sang; 1985; 48(6):325-32. PubMed ID: 4013136
[TBL] [Abstract][Full Text] [Related]
4. Virus safety of a pasteurized antithrombin III concentrate. Preclinical and clinical data.
Clemens R; Weidmann E; Merkle W; Bock HL; Mauler R; Hilfenhaus J
Arzneimittelforschung; 1987 Jul; 37(7):759-62. PubMed ID: 3675669
[TBL] [Abstract][Full Text] [Related]
5. [Properties and virus safety of a pasteurized antithrombin III concentrate].
Karges HE; Fuhge P; Heimburger N
Arzneimittelforschung; 1987 Jul; 37(7):756-8. PubMed ID: 2823838
[TBL] [Abstract][Full Text] [Related]
6. [Preparation and characterization of an antithrombin III concentrate].
Dornheim G; Schön R
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(6):870-7. PubMed ID: 6187640
[TBL] [Abstract][Full Text] [Related]
7. US FDA approves a new blood screening test for HIV and hepatitis B and C.
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):5. PubMed ID: 19622052
[No Abstract] [Full Text] [Related]
8. [Isolation and characteristics of antithrombin III from human plasma].
Markova OA; Kalashnikov VV; Khvatov VB
Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin III concentrates--are they clinically useful?
Lechner K; Kyrle PA
Thromb Haemost; 1995 Mar; 73(3):340-8. PubMed ID: 7667814
[TBL] [Abstract][Full Text] [Related]
10. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
[TBL] [Abstract][Full Text] [Related]
11. [Abnormal antithrombin III].
Sakuragawa N
Rinsho Byori; 1987 Apr; Spec No 70():187-201. PubMed ID: 3302389
[No Abstract] [Full Text] [Related]
12. Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
Reif OW; Freitag R
Bioseparation; 1994 Dec; 4(6):369-81. PubMed ID: 7765681
[TBL] [Abstract][Full Text] [Related]
13. Purity, activity, and virus safety of a pasteurized antithrombin concentrate.
Gröner A; Nowak T; Römisch J
Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():79-86. PubMed ID: 12016583
[No Abstract] [Full Text] [Related]
14. [Purification of antithrombin III by affinity chromatography in heparin-Trisacryl].
Allary M; Boschetti E; Majurel M; Girot P; Saint-Blancard J
Ann Pharm Fr; 1986; 44(5):379-86. PubMed ID: 3579161
[No Abstract] [Full Text] [Related]
15. High and low anticoagulant activity heparins. Preparation in large scale and degree of complexation with antithrombin III.
Takahashi HK; Nader HB; Dietrich CP
Arzneimittelforschung; 1985; 35(11):1620-3. PubMed ID: 4091864
[TBL] [Abstract][Full Text] [Related]
16. Monitoring plasma antithrombin-III levels during infusion of antithrombin-III concentrate.
Jespersen J
Thromb Haemost; 1984 Oct; 52(2):214. PubMed ID: 6523438
[No Abstract] [Full Text] [Related]
17. Heat inactivation of human immunodeficiency virus in solutions of antithrombin III.
Einarsson M; Perenius L; McDougal JS; Cort S
Transfusion; 1989 Feb; 29(2):148-52. PubMed ID: 2919425
[TBL] [Abstract][Full Text] [Related]
18. Three novel high performance affinity chromatographic media for the separation of antithrombin III from human plasma.
Zhao Y; Zhao R; Shangguan D; Xiong S; Liu G
Biomed Chromatogr; 2001 Dec; 15(8):487-92. PubMed ID: 11748680
[TBL] [Abstract][Full Text] [Related]
19. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
Ono I
Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
[TBL] [Abstract][Full Text] [Related]
20. [Procedures for the isolation and characterization of human antithrombin III].
Trobisch H; Wüst T; Rustige H
Behring Inst Mitt; 1986 Feb; (79):177-90. PubMed ID: 3718405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
